Detry-Morel M
St Luc University Hospital, Université Catholique de Louvain, Brussels.
Bull Soc Belge Ophtalmol. 2007(303):87-95.
The Proview phosphene (eye-pressure) tonometer and the Rebound tonometer ICare are relatively new devices basically different from the Goldmann applanation tonometry (GAT). Both technologies will be presented in this review with respect to their principle, their technique, their advantages and limits, as well as their accuracy, the IOP measurements agreement with GAT, and the influence of central corneal thickness on the reliability of these measurements. Because the current data base for the interpretation of glaucoma disease course and its management are still relatively small, the development of a continuous, accurate, reliable and harmless monitoring of IOP over 24 hours is strongly desirable in the future. Approaches for self-tonometry and devices such as smart contact lenses which can take the IOP from the corneal surface have been developed with this goal. The future will probably confirm whether telemetric IOP monitoring with an implantable active microsystem allows a reliable IOP monitoring or not. In any case, active implants will open new and important perspectives in the diagnosis and the treatment of glaucomatous optic neuropathy.
宝视德(Proview)压平眼压计和回弹式眼压计Icare是相对较新的设备,与戈德曼压平眼压测量法(Goldmann applanation tonometry,GAT)有本质区别。本综述将介绍这两种技术的原理、操作方法、优缺点、准确性、眼压测量值与GAT的一致性,以及中央角膜厚度对这些测量可靠性的影响。由于目前用于解释青光眼病程及其治疗的数据基础仍然相对较小,未来非常需要开发一种能在24小时内持续、准确、可靠且无害地监测眼压的方法。为实现这一目标,已经开发了自我眼压测量方法以及诸如智能隐形眼镜之类能从角膜表面获取眼压的设备。未来可能会确定植入式有源微系统的遥测眼压监测是否能实现可靠的眼压监测。无论如何,有源植入物将为青光眼性视神经病变的诊断和治疗开辟新的重要前景。